Latest Breaking News On - Bridgebio pharma inc - Page 10 : comparemela.com

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)

Boone Capital Management LLC Makes New $8.26 Million Investment in BridgeBio Pharma, Inc. (NASDAQ:BBIO)
themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.

Bridgebio-pharma
Randalw-scott
Bio-pharma
Hannah-valantine
Cantor-fitzgerald
Topco-ltd
Bridgebio-pharma-company-profile
Bridgebio-pharma-inc
Securities-exchange-commission
Wells-fargo-company
Boone-capital-management
Citigroup

BridgeBio Pharma (NASDAQ:BBIO) Announces Earnings Results, Misses Estimates By $0.09 EPS

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) posted its quarterly earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing the consensus estimate of ($0.87) by ($0.09), Briefing.com reports. The business had revenue of $1.74 million during the quarter, compared to the consensus estimate of $4.78 million. BridgeBio Pharma’s revenue for the […]

Frank-mccormick
Hannah-valantine
Bio-pharma
Bridgebio-pharma
Nasdaq
Quantamental-technologies
Bridgebio-pharma-inc
Citigroup
Cantor-fitzgerald
Mercer-global-advisors-inc
Wells-fargo-company
Get-free-report

BridgeBio Pharma (NASDAQ:BBIO) Issues Earnings Results

BridgeBio Pharma (NASDAQ:BBIO – Get Free Report) issued its earnings results on Thursday. The company reported ($0.96) EPS for the quarter, missing analysts’ consensus estimates of ($0.87) by ($0.09), Briefing.com reports. The company had revenue of $1.74 million for the quarter, compared to the consensus estimate of $4.78 million. The firm’s revenue for the quarter […]

Frank-mccormick
Randalw-scott
Bridgebio-pharma
Bio-pharma
Cantor-fitzgerald
Topco-ltd
Bridgebio-pharma-company-profile
Wells-fargo-company
Ameritas-investment-partners-inc
Citigroup
Securities-exchange-commission
Bridgebio-pharma-inc

BridgeBio Pharma Reports Fourth Quarter and Full Year 2023 Financial Results and Business Update

- Submitted New Drug Application to US Food and Drug Administration for acoramidis for the treatment of transthyretin amyloid cardiomyopathy based on positive results of Phase 3 ATTRibute-CM trial,.

United-states
Ukraine
Australia
Israel
Gaza-strip
Japan
American
Japanese
Neil-kumar
Brian-stephenson
Vikram-bali
Drug-administration

BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 9c

BridgeBio Pharma Inc. (BBIO) Misses Q4 EPS by 9c
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Bio-pharma-inc
Bridgebio-pharma-inc
Nasdaq
Bridgebio-pharma